Three hundred CM-Dil labeled A549 xenograftzebrafish embryos were randomly chosen and seeded into 10 replicate wells in 6-well cell culture plates (30 embryos per well). Different concentrations of bevacizumab (28 ng, 83 ng and 250 ng per embryo), apatinib (0.057 μg/mL, 0.167 μg/mL and 0.5 μg/mL) and endostar (11 ng, 33 ng and 99 ng per embryo) were applied. After incubation for 3 days at 35 °C, ten out of 30 embryos from each well were randomly chosen and photographed under a fluorescence microscope. The fluoresce intensity of tumor in the embryos (Z) was measured and tumor inhibition rate was calculated according to the following formula:
Copyright and License information: The Author(s) ©2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.